BIONICS Israel Trial
NCT02834806
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
58
Enrollment
INDUSTRY
Sponsor class
Conditions
Stenosis
Interventions
DEVICE:
BioNIR Ridaforolimus Eluting Coronary Stent System
Sponsor
Medinol Ltd.